KT Medical Service Public Company LimitedSET: KTMS🇹🇭 TH

MD&A · 2025

Overview of Operations

Overview of Operations

Business characteristics of the Company and its subsidiaries.

  1. KT Medical Services Public Company Limited ("KTMS") operates a business providing hemodialysis services, both in the form of specialized hemodialysis clinics (clinics or stand-alone) and hemodialysis units in hospitals (hemodialysis units or outsourced). Currently, there are 36 hemodialysis units (with 511 hemodialysis machines), comprising 2 branches in Bangkok, 16 branches in the Northeast, 4 branches in the West, 7 branches in the North, 2 branches in the Central region, 2 branches in the East, and 3 branches in the South.

  2. Nephro Vision Company Limited ("NEP") operates a business providing hemodialysis services in the form of specialized hemodialysis clinics (clinics or stand-alone). Currently, there are 3 hemodialysis units (with 37 hemodialysis machines), comprising 2 branches in the North and 1 branch in the West.

  3. Irving Corporation Company Limited ("IRV") operates 4 main businesses, namely:

3.1) Operates a business providing design and installation services for pure water production systems, wastewater treatment systems for hemodialysis, and system maintenance.

3.2) Production and distribution of hemodialysis solutions.

3.3) Design and decoration services for hemodialysis medical facilities.

3.4) Design, assembly, and distribution of medical equipment for hemodialysis medical facilities.

  1. Medical Vision Company Limited ("MV") operates a business providing design and installation services for pneumatic tube systems for medical specimens, as well as system maintenance services.

Operating Results & Financial Condition

Operating Results & Profitability

Revenue from sales and services

Revenue from sales and services increased by 107.03 million Baht or 17.91 percent from the previous year, which can be categorized by business group as follows:

Hemodialysis service business group

Revenue from the hemodialysis service business group increased by 106.21 million Baht or 21.95 percent from the previous year, primarily due to an increase in the number of patients receiving services and continuous branch expansion.

Business group providing design, installation of pure water production systems, wastewater treatment systems, hemodialysis centers, and system maintenance services

Revenue from the business group providing design, installation of pure water production systems, wastewater treatment systems, hemodialysis centers, and system maintenance services increased by 0.26 million Baht or 0.30 percent from the previous year, primarily due to

  • Revenue from the production and distribution of dialysis solutions decreased by (6.66) million Baht or (14.10) percent from the previous year, due to reduced orders from some customers.

  • Revenue from design and decoration services for hemodialysis centers increased by 2.59 million Baht or 41.18 percent from the previous year, due to an increase in the number and value of kidney unit renovation projects compared to the previous year.

  • Revenue from design and installation services and pure water system maintenance services increased by 5.20 million Baht or 19.48 percent from the previous year, due to an increase in the number and value of water system projects compared to the previous year.

  • Revenue from the distribution of medical equipment for dialysis centers decreased by (0.87) million Baht or (11.57) percent from the previous year, due to a decrease in medical equipment sales compared to the previous year.

Business group providing design and installation of pneumatic tube systems for medical specimen transport

Revenue from the business group providing design and installation of pneumatic tube systems for medical specimen transport increased by 0.56 million Baht or 2.14 percent from the previous year, due to an increase in the value of pneumatic tube system installation projects for medical specimen transport compared to the previous year.

Administrative expenses

The Group's administrative expenses increased by 1.90 million Baht or 2.89 percent from the previous year, primarily due to expenses related to the preparation for opening new company branches and depreciation of new office and warehouse lease agreements of the Group, among others.

Net operating results

The Group's net profit increased by 25.63 million Baht or 138.84 percent from the previous year, primarily due to an increase in operating profit from the hemodialysis service business group and the business group providing design and installation of pneumatic tube systems for medical specimen transport.

Liquidity & Capital Adequacy

Cash Flow Statement Analysis

Cash Flow from Operating Activities

The Group had cash flow from operating activities of 42.52 million Baht, derived from operating profit, depreciation, and amortization. Meanwhile, cash flow from operating activities decreased due to an increase in trade receivables and other receivables, which rose in line with the growing number of patients and treatments.

Cash Flow from Investing Activities

The Group had cash used in investing activities of (99.03) million Baht, as 2025 saw payments for the acquisition of buildings, building construction, and decoration of dialysis units, including hemodialysis machines and various equipment for newly opened branches, as well as the purchase of trading securities within 2025.

Cash Flow from Financing Activities

The Group had cash flow from financing activities of 24.02 million Baht, primarily due to receiving long-term loans from banks and proceeds from sale-and-leaseback agreements for hemodialysis machines in 2025. Meanwhile, cash flow from financing activities decreased due to the repayment of long-term bank loans and dividend payments in 2025.

Financial Ratios

Consolidated Financial Statements

2566

2567

2568

Liquidity Ratios

Liquidity Ratios

(times)

2.61

1.81

2.10

Quick Ratio

(times)

1.86

1.44

1.60

Cash Flow Liquidity Ratio

(times)

0.01

0.37

0.20

Trade Receivables Turnover Ratio

(times)

2.28

2.43

2.40

Average Collection Period

(days)

158

148

150

Inventory Turnover Ratio

(times)

5.28

5.94

5.88

Average Inventory Holding Period

(days)

68

61

61

Trade Payables Turnover Ratio

(times)

1.76

1.70

1.65

Payment Period

(days)

205

212

218

Cash Conversion Cycle

(days)

21

(3)

(7)

Profitability Ratios

Gross Profit Margin

(percentage)

18.23

16.22

18.93

Net Profit Margin

(percentage)

2.94

3.07

6.22

Return on Equity

(percentage)

2.77

3.69

8.41

Operating Efficiency Ratios

Return on Assets

(percentage)

2.02

2.59

5.51

Return on Fixed Assets

(percentage)

17.79

18.29

27.03

Asset Turnover Ratio

(times)

0.69

0.85

0.88

Financial Policy Analysis Ratios

Debt-to-Equity Ratio

(times)

0.34

0.51

0.55

Interest Coverage Ratio

(times)

7.52

8.05

10.67

Debt Service Coverage Ratio

(times)

0.01

0.77

0.48

Financial Ratio Analysis

Liquidity Ratios

Liquidity ratios increased compared to 2024, driven by an increase in current assets from receivables, which rose in line with the number of patients and treatments of the company and its subsidiaries. Meanwhile, current liabilities increased slightly.

Average Collection Period

The average collection period increased compared to 2024, due to a higher proportion of average receivables relative to the increase in revenue. However, the Group regularly monitors long-overdue receivables on a monthly basis.

Gross Profit Margin

Gross profit margin increased compared to 2024, as the Group's profit from the hemodialysis business increased due to a rise in the number of patients and treatments. Additionally, the subsidiary's profit from air duct installation work increased due to better cost control for air duct installation.

Net Profit Margin

Net profit margin increased compared to 2024, as the Group's profit from the hemodialysis business increased due to a rise in the number of patients and treatments. Additionally, the subsidiary's profit from air duct installation work increased due to better cost control for air duct installation.

Return on Equity

Return on equity increased compared to 2024, as the Group's operating profit increased in 2025 due to a rise in the number of patients and treatments. Meanwhile, average shareholders' equity increased slightly.

Return on Assets

Return on assets increased compared to 2024, as the Group's operating profit increased in 2025 due to a rise in the number of patients and treatments. Meanwhile, average assets increased at a lower proportion than the increase in operating profit, driven by an increase in trade receivables corresponding to the growing number of patients and treatments.

Debt-to-Equity Ratio

The debt-to-equity ratio increased compared to 2024, due to an increase in other financial liabilities of the company and its subsidiaries, resulting from an increase in sale-and-leaseback agreements for hemodialysis machines and an increase in long-term bank loans for the company and its subsidiaries in 2025. Meanwhile, shareholders' equity increased at a lower proportion than liabilities.

Company Direction in 2026

KT Medical Service Public Company Limited. The company currently has plans for continuous branch expansion and an increase in hemodialysis machines. It is expected that by Q1 2026, approximately 1-2 branches will be expanded and 18-42 hemodialysis machines will be added, depending on the economic situation.

Nephro Vision Co., Ltd. The company currently plans to add approximately 1-2 hemodialysis machines by Q1 2026.

Irving Corporation Co., Ltd. The company has currently received orders for water system installation work from customers for 5 projects, with a total value of 4.00 million Baht. Installation is expected to be completed in Q1 2026.

Medical Vision Co., Ltd. The company has currently received an order for the installation of a pneumatic tube system for medical specimen transport from a customer for 1 project, with a total value of 1.03 million Baht. Installation is currently underway and is expected to be completed in Q1 2026.

Asset Management Capability

Assets

Overall assets as of December 31, 2025, increased by 77.85 million Baht or 10.22 percent from the end of 2024. Significant changes include:

Cash and cash equivalents decreased by (32.49) million Baht. primarily from the payment of the group's annual bonus for 2024, the payment of liabilities for dialysis machines, and the purchase of trading securities by the company and its subsidiaries, including the company's dividend payments for 2025, while increasing from the sale and leaseback agreement for dialysis machines with a leasing company in 2025.

Trade and other current receivables increased by 69.78 million Baht. from the increased number of patients and treatments in the dialysis service business of the company and its subsidiaries.

Other current financial assets increased by 25.49 million Baht. from the purchase of trading securities during 2025.

Right-of-use assets increased by 12.57 million Baht. from the renewal of new office and warehouse lease agreements by the group and entering into new vehicle lease agreements for additional use and to replace old vehicles whose contracts have expired by the group.

Liabilities

Overall liabilities as of December 31, 2025, increased by 40.75 million Baht or 15.93 percent from the end of 2024. Material changes include:

Trade and other current payables decreased by (19.92) million Baht. from payments to creditors for dialysis machines by the company and its subsidiaries, including the payment of the group's annual bonus for 2024.

Long-term bank loans increased by 11.14 million Baht. from receiving bank loans in 2025 by the company and its subsidiaries.

Lease liabilities increased by 12.62 million Baht. from the renewal of new office and warehouse lease agreements by the group and entering into new vehicle lease agreements for additional use and to replace old vehicles whose contracts have expired by the group.

Other financial liabilities increased by 29.43 million Baht. from the sale and leaseback agreement for dialysis machines with a leasing company in 2025.

Shareholders' equity

Overall shareholders' equity as of December 31, 2025, increased by 37.10 million Baht or 7.33 percent from the end of 2024, due to an increase in retained earnings from the group's operating profit for 2025 of 44.09 million Baht and decreased by dividend payments of (6.98) million Baht.

Debt Securities with Financial Ratio Requirements

Debt Securities with Financial Ratio Requirements Issued?

Yes

Can the Company Maintain the Reported Financial Ratios?

No

Explanation

Under the loan agreement, the subsidiary must comply with certain financial covenants as stipulated in the agreement, including maintaining the debt-to-equity ratio, current ratio, and debt service coverage ratio in accordance with the conditions specified in the agreement.

However, as of December 31, 2025, the subsidiary was unable to comply with the financial covenant requirements under the loan agreement with the bank. Therefore, the subsidiary reclassified long-term loans due in more than one year, totaling 19.6 million Baht, to be presented as part of long-term loans due within one year in their entirety. The management of the subsidiary has sent a letter to the bank requesting a waiver for the non-compliance with the financial covenant. Management believes that the subsidiary will receive a waiver from the bank for its non-compliance with the financial covenant, and that this will not affect the liquidity and financial position of the group.

Factors That May Affect Financial Condition

Factors or Incidents That May Materially Affect Financial Condition

Details refer to "Part 3 Financial Statements, Section Notes to Financial Statements, Item 34.1 Objectives and Policies for Financial Risk Management."

Contents